Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-28

Clinical Trial Update: Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating botulinum toxin type A for treating glabellar lines; study completed assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Skin Aging | Phase 3 | Status: COMPLETED